0001209191-20-008815.txt : 20200212
0001209191-20-008815.hdr.sgml : 20200212
20200212165350
ACCESSION NUMBER: 0001209191-20-008815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandercock Colin
CENTRAL INDEX KEY: 0001724870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 20605011
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-05
0
0001645460
Cue Biopharma, Inc.
CUE
0001724870
Sandercock Colin
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP, General Counsel and Sec
Stock Option (right to buy)
16.26
2020-02-05
4
A
0
20000
0.00
A
2030-02-05
Common Stock
20000
20000
D
This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 5, 2020.
/s/ Colin Sandercock by Mark Busch, as attorney-in-fact
2020-02-12